Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)

China · Delayed Price · Currency is CNY

39.45

+0.22 (0.56%)

Jun 18, 2026, 2:25 PM CST

-45.09% (1Y)

Market Cap	7.59B -48.0%
Revenue (ttm)	1.52B +4.6%
Net Income	264.89M -29.9%
EPS	1.37 -31.3%
Shares Out	193.44M
PE Ratio	28.56
Forward PE	17.45
Dividend	0.32 (0.82%)
Ex-Dividend Date	Jun 22, 2026

Volume	2,329,701
Open	39.15
Previous Close	39.23
Day's Range	38.95 - 40.37
52-Week Range	38.20 - 83.83
Beta	0.32
Analysts	Buy
Price Target	71.66 (+81.65%)
Earnings Date	Aug 21, 2026

About SHA:688050

Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for ophthalmic surgery, refractive error correction, and optometry consumption. Eyebright Medical Technology (Beijing) Co., Ltd. was founded in 2010 and is hea... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2010

Employees 2,331

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688050

Full Company Profile

Financial Performance

In 2025, SHA:688050's revenue was 1.48 billion, an increase of 5.15% compared to the previous year's 1.41 billion. Earnings were 268.17 million, a decrease of -30.96%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 688050 stock is "Buy." The 12-month stock price target is ¥71.66, which is an increase of 81.65% from the latest price.

Price Target

¥71.66

(81.65% upside)

Analyst Consensus: Buy

Stock Forecasts